Velarion Records
Free. Unsubscribe any time.

Keros Therapeutics, Inc. (KROS)

Keros Therapeutics, Inc. filed 12 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 12 transactions and 55,976 shares. None carries the SEC's AFF10B5ONE flag; all 12 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Keros Therapeutics, Inc. 12

Adoption dates in Keros Therapeutics, Inc. 4

Results prints in Keros Therapeutics, Inc. 0

Trades before a print in Keros Therapeutics, Inc. 0

Interval to Keros Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Keros Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 5, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.